"Through the advancement of our platforms, we will build a fully integrated data economy. At Topia Life Sciences, we are passionate about improving health outcomes for people around the world." - Kamlesh Patel, Founder.
We are changing the face of Alzheimer’s care with our AI technology. Our goal is to enable early detection and precise monitoring of Alzheimer’s so patients and healthcare professionals can act early. By using AI and the latest neuroimaging, we provide accuracy and consistency in diagnostics to improve patient outcomes and quality of life. Trust Alzevita to change how we understand, detect, and care for Alzheimer’s one step at a time.
Our MedTech platform is focused on neurodegenerative disease diagnostics. Alzevita gives clinicians the tools to identify and track key biomarkers such as hippocampal volume, which is critical in the early stages of Alzheimer’s. Our approach supports early intervention and ongoing care for patients and providers.
Alzevita’s proprietary platform uses AI algorithms to automatically segment and volumetrically analyze the hippocampus, the region of the brain responsible for memory and learning which is often the first to be affected by Alzheimer’s. This ensures objective and reproducible measurements so clinicians have the data to diagnose, monitor and personalize treatments. Alzevita enables a more informed and personalized approach to Alzheimer’s care.
